{
    "title": "114_hr5216",
    "content": "The \"Opioid and Heroin Abuse Crisis Investment Act of 2016\" authorizes $1,164,600,000 for fiscal years 2017 and 2018 to improve opioid prescribing practices, expand access to substance use treatment, and reduce opioid use disorders and overdose. This funding will be available through State Targeted Response Cooperative Agreements. The Secretary will enter into targeted response cooperative agreements with States to expand opioid treatment capacity and make services more affordable. Funding allocation will be based on the severity of the opioid epidemic and the State's response strategy. States must use funds to expand treatment capacity, make services affordable, and support individuals seeking treatment and recovery. $465,000,000 is appropriated for this purpose from the Opioid and Heroin Abuse Crisis Investment Act. The Opioid and Heroin Abuse Crisis Investment Act allocates $465,000,000 for expanding opioid treatment capacity and making services more affordable. Additionally, $25,000,000 is designated for enhanced loan repayment awards to increase clinicians with medication-assisted treatment training. The Public Health Service Act is amended to include a new section after section 510, focusing on expanding opioid treatment capacity and making services more affordable. The Public Health Service Act is amended to include a new section after section 510, focusing on expanding opioid treatment capacity and making services more affordable. This new section, SEC. 511, pertains to the evaluation of medication-assisted treatment. The Secretary will evaluate treatment outcomes for patients with opioid addiction receiving medication-assisted treatment to reduce opioid use disorders, overdose, and death. $15,000,000 is allocated for this purpose annually from the Opioid and Heroin Abuse Crisis Investment Act. The Secretary will use funds to award grants to States for medication-assisted treatment for prescription drug and opioid addiction, including psychosocial services and coordination with HIV or hepatitis C services. $50,100,000 is allocated for this purpose in fiscal year 2017. Additionally, guidelines for preventing prescription drug overdose will be disseminated under the Public Health Service Act. The Director of the Centers for Disease Control and Prevention will disseminate guidelines to improve opioid prescribing practices to reduce opioid use disorders and overdose. Funds will be used to pilot test, evaluate, and adapt tools and strategies to convey opioid prescribing guidelines in accessible formats for healthcare providers. The bill aims to develop clinical decision support tools based on CDC opioid prescribing guidelines, provide training modules for healthcare professionals, and collaborate with the Office of the National Coordinator for Health Information Technology for effective dissemination of guidelines. The Rural Opioid Overdose Reversal Grant Program under the Public Health Service Act allows for grants to eligible rural entities for opioid misuse and overdose prevention, intervention, and treatment. Eligible entities must be rural public or nonprofit private organizations. The Rural Opioid Overdose Reversal Grant Program provides grants to eligible rural entities for opioid misuse education, prevention, and treatment. Funds can be used for training healthcare professionals and first responders in recognizing opioid overdose signs, administering naloxone, and providing transportation to hospitals for continued care. The Prescription Drug Overdose Initiative under the Public Health Service Act aims to allocate $10,000,000 from the Opioid and Heroin Abuse Crisis Investment Act for fiscal year 2017. This initiative includes referring individuals with drug dependency to substance use disorder treatment centers and purchasing naloxone and opioid overdose reversal devices. The National Coordinator will use $5,000,000 from the Opioid and Heroin Abuse Crisis Investment Act to harmonize technical standards for prescription drug monitoring programs and health information technology interoperability. The Bureau of Prisons will utilize funds to support drug treatment programs within its facilities. The Bureau of Prisons will expand drug treatment programs, including medication-assisted treatment, with $3,000,000 allocated from the Opioid and Heroin Abuse Crisis Investment Act. The Second Chance Act of 2007 will also focus on community reintegration to reduce recidivism and enhance public safety. The Opioid and Heroin Abuse Crisis Investment Act allocates funds for various substance abuse treatment programs, including residential treatment and aftercare services for inmates. The Opioid and Heroin Abuse Crisis Investment Act allocates $14,000,000 for fiscal year 2017 for heroin enforcement groups under the Controlled Substances Act. The Attorney General will establish new heroin enforcement groups within the Drug Enforcement Administration using $12,500,000 from the Opioid and Heroin Abuse Crisis Investment Act for fiscal year 2017."
}